Zinzino
February 28, 2022
Zinzino said full-year 2021 total revenues rose 20 percent to 1,370.6 million Swedish kronor, with EBITDA of 137.6 million kronor and an EBITDA margin of 10.0 percent. Fourth-quarter revenues rose 18 percent to 401.2 million kronor, while EBITDA was 26.4 million kronor. The board proposed a dividend of 2.00 kronor per share, up from 1.25 kronor.
The company said it launched Vitamin D Test and ZinoShine+ in the fourth quarter and started sales in South Africa on November 9 as its first African market. Cash flow from operating activities for the year was 153.5 million kronor, and liquid assets at year-end were 235.7 million kronor. Chief executive Dag Bergheim Pettersen presented the year-end report.